VITA NICHOLAS 4
4 · Cannabist Co Holdings Inc. · Filed Dec 26, 2023
Insider Transaction Report
Form 4
VITA NICHOLAS
DirectorCEO
Transactions
- Sale
Common Shares
2023-12-22$0.39/sh−200,000$77,680→ 18,127,075 total(indirect: By LLC) - Gift
Common Shares
2023-12-15−1,000,000→ 18,727,075 total(indirect: By LLC) - Sale
Common Shares
2023-12-20$0.39/sh−100,000$39,000→ 18,627,075 total(indirect: By LLC) - Sale
Common Shares
2023-12-21$0.38/sh−300,000$112,680→ 18,327,075 total(indirect: By LLC)
Holdings
- 618,950(indirect: By LLC)
Common Shares
Footnotes (5)
- [F1]Transaction represents contribution of shares by the Reporting Person for pediatric genetic and medical research for orphan and ultra rare illnesses, educational and other philanthropic purposes.
- [F2]The sales price reported above was converted from the Canadian sales price of $0.52 using an exchange rate of C$1.3331 = US$1.00.
- [F3]The sale price reported above was converted from the Canadian sale price of C$0.50 using an exchange rate of C$1.3311 = US$1.00.
- [F4]Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, education and philanthropic purposes.
- [F5]The sale price reported above was converted from the Canadian weighted average price of C$0.515 using an exchange rate of C$1.3258 = US$1.00. These shares were sold in multiple transactions at prices ranging from C$0.51 to C$0.52, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.